Recharged Trump Holds Press Conference | Eastern North Carolina Now

The president was on his game Monday.

ENCNow
Publisher's note: This post appears here courtesy of the LifeZette, and written by Polizette Staff.

    At last Friday's daily coronavirus briefing President Trump was clearly frustrated with the press and on a very short fuse. But after taking the weekend off and jettisoning the entire concept of a detailed daily virus brief, a comms idea that had long since run its course, the president appeared for a regular presser in the Rose Garden Monday reinvigorated and with a cool and calm attitude that transcended press hijinks.

    President Trump began by thanking and applauding the efforts of private sector partners in the virus fight such as LabCorp, Roche, Abbott, Walmart, Quest, CVS, Walgreens, and several others. Their ramped up ability in regards to testing is making the national reopening an approaching reality.

    He then pivoted to the Chinese. Trump once more blamed them for lying to the rest of the world about the virus, both now and in the early stages. He said, "We are not happy with the Chinese" and, per Chinese actions, "the whole world is suffering because of it." When asked by a reporter what actions the administration might take in response against the Chinese, the president demurred on a specific answer but said the matter was under serious investigation.

    When the liberal press tried to bait him he deftly parried them and moved on. He did this first when a biased reporter tried to use an old quote attributed to HHS Secretary Azar against the Secretary and second, as this publication predicted, on the contrived disinfectant controversy.

    He also employed canny rhetorical jujitsu when a media type tried to imply he supported conspiracy theories on inflated death rates. The president just shut them all down with a concise and serene sentence or two. The reporters were glaringly rattled he would not engage with them. Well played, sir.

    Trump mentioned that Germany is asking the Chinese for $130 billion in damages and said the U.S. may do something on that score as well but did not specify a number. He said, while the second quarter would be hard, the U.S. economy should rebound very well in the third and fourth quarters. He finished with brushing off a reporter who asked an absurd question on changing the November election date.
Go Back


Leave a Guest Comment

Your Name or Alias
Your Email Address ( your email address will not be published)
Enter Your Comment ( no code or urls allowed, text only please )




Missouri Sues China Over COVID-19 Pandemic Guest Editorial, Editorials, Op-Ed & Politics Three States Gradually Reopen, as Others Plan to Lift Regulations


HbAD0

Latest Op-Ed & Politics

The existing School Board should vote to put this project on hold until new Board is seated
At least one person was shot and killed during an assassination attempt on former President Donald Trump on Saturday at a political rally in Pennsylvania in which the suspected gunman was also “neutralized,” according to the U.S. Secret Service.
As everyone now knows, the U.S. Supreme Court's ruling to grant presidents immunity for "official acts" has given Donald Trump unlimited power to do literally anything he wants with zero consequences whatsoever.
President Joe Biden formally rejected on Monday a bill in Congress that would require individuals to show proof of U.S. citizenship to register to vote in elections for federal office.
Watch and be sensitive to the events which will possibly unfold in the coming days.

HbAD1

illegal alien "asylum seeker" migrants are a crime wave on both sides of the Atlantic
majority of board member are rubberstamps for liberal superintendant
like the old Soviet Union, Biden put DEI political officers in the military
ssick perverts running Deere sponsored homosexual event for 3 year olds

HbAD2

appoints new pro-cnesorship White House official
Those with access to President Joe Biden behind closed doors say that his condition is deteriorating at an accelerated rate

HbAD3

 
Back to Top